Ligand-based modelling Followed by in Vitro Bioassay Yielded New Potent Glucokinase ActivatorsMutasem O.Taha, Maha Habash, Ma’mon M. Hatmal, Ahmed H. Abdelazeem, Amjad Qandil "Ligand-based modelling Followed by in Vitro Bioassay Yielded New Potent Glucoki

  • Print

Mutasem O.Taha, Maha Habash, Ma’mon M. Hatmal, Ahmed H. Abdelazeem, Amjad Qandil "Ligand-based modeling Followed by in Vitro Bioassay Yielded New Potent Glucokinase Activators"  -Journal of Molecular Graphics and Modelling |Volume 56, March 2015, Pages 91-102 |https://doi.org/10.1016/j.jmgm.2014.12.003 

 

Please click here to see the article.

Does the patients' educational level and previous counseling affect their medication knowledge?

  • Print

Abdulmalik M. Alkatheri, Abdulkareem M. Albekairy  “Does the patients' educational level and previous counseling affect their medication knowledge?”    -Annals of Thoracic Medicine - Vol 8, Issue 2, April-June 2013 |DOI.org/10.4103/1817-1737.109823 

 

Please click here to see the article.

Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction

  • Print

Amjad M. Qandil, Shereen M. Assaf, Enas A. Al Ani, Alaa Eldeen Yassin, Aiman A. Obaidat   “Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction”    -Journal of Pharmaceutical Investigation | June 2013, Volume 43, Issue 3, pp 171–183 |DOI.org/10.1007/s40005-013-0065-4

 

Please click here to see the article.

Methoxyphenylcipro induces antitumor activity in human cancer cells

  • Print

Nizar M. Mhaidat, Amjad M. Qandil, Qosay A. Al-Balas, Mohammad A. Hassan, Saied A. Jaradat, Ahmad M. Matalkah, Rick T. Thorne   “Methoxyphenylcipro induces antitumor activity in human cancer cells”    -Archives of Pharmacal Research |August 2013, Volume 36, Issue 8, pp 1023–1028 |DOI.org/10.1007/s12272-013-0087-5

 

Please click here to see the article.

Cytochrome P450 3A4*1B as Pharmacogenomic

  • Print

Abdulkareem Albekairy, Abdulmalik Alkatheri, Shiro Fujita, Alan Hemming, Richard Howard, Alan Reed, Janet Karlix    "Cytochrome P450 3A4*1B as Pharmacogenomic Predictor of Tacrolimus Pharmacokinetics and Clinical Outcome in the Liver Transplant Recipient"    -The Saudi Journal of Gastroenterology |Year:2013  |Volume:19  |Issue:2  |Page : 89-95 |DOI.org/10.4103/1319-3767.108484

 

Please click here to see the article.

More Articles...

  1. Mesoporous silica based macromolecules for dissolution enhancement of Irbesartan drug using pre-adjusted pH method
  2. Stability of Recombinant Tissue Plasminogen Activator at -30C over One Year
  3. Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review
  4. Medication Adherence among Adult Saudi Hemodialysis Patient

College of Pharmacy - KSAU-HS © 2012 - 2022